About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Monthly Archives: September 2009
Rx 4 Good
In today's environment there is a dichotomy for the pharmaceutical industry when it comes to good corporate social responsibility. Here it is. In the aggregate, the pharmaceutical and biotech industry actually provide a very very large contributions through philanthropy that … Continue reading
Posted in Useful Resources
1 Comment
Are OTCs Just O – as in Over?
In the 1990s the number of drugs that switched from Rx status to Over-the-Counter (OTC) was quite high and the Non-prescription Drugs Advisory Committee (NDAC) was having a lot of meetings to consider switches of several heartburn remedies, allergy medications … Continue reading
Posted in OTC Switches
1 Comment
What Are They Smoking? Tobacco Companies Sue FDA
Well, it was probably inevitable. Some tobacco companies have filed a First Amendment based lawsuit aimed at the newly enacted legislation that gives FDA authority to regulate communications over tobacco marketing. Here is why they will lose. First of all, … Continue reading
Posted in FDA Policy
Comments Off on What Are They Smoking? Tobacco Companies Sue FDA